September 2025
1. HUANG J, Zhong CC, Li Z, Jiang Y, et al
   Machine Learning Predictive Models for Survival in Gastric Cancer Patients with Diabetes: a population-based cohort study.
   Oncology. 2025 Sep 4:1-35. doi: 10.1159/000548220.
   

   >> Share

   
   June 2025
2. WANG YT, Guo T, Hui Y, Na Z, et al
   Association between HER-2 and lymph node metastasis in gastric cancer: a meta-analysis.
   Oncology. 2025 Jun 12:1-19. doi: 10.1159/000546630.
   

   >> Share

   
   May 2025
3. LIU MX, Chu KM
   Endogenous and extracellular roles of a tumor suppressor miR-379-5p in gastric cancer.
   Oncology. 2025 May 26:1-16. doi: 10.1159/000546620.
   

   >> Share

   
   February 2025
4. SHANG H, Fang Y, Zhao Y, Mi N, et al
   Deep learning and radiomics for gastric cancer lymph node metastasis: Automated segmentation and multi-machine learning study from two centers.
   Oncology. 2025 Feb 13:1-20. doi: 10.1159/000544179.
   

   >> Share

   
   January 2025
5. ALREHAILI M, Phillips WJ, Asmis T, Vickers M, et al
   A Retrospective Analysis of the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors at The Ottawa Hospital Cancer Center over the Last Decade Including COVID-19 Pandemic Period.
   Oncology. 2025;103:421-426.
   

   >> Share

   
   December 2024
6. ZHAO T, Wu Q, Zhu C, Da M, et al
   Diagnostic value of artificial intelligence-based pathology diagnosis system in lymphatic metastasis of gastric cancer.
   Oncology. 2024 Dec 2:1-13. doi: 10.1159/000542852.
   

   >> Share

   
   November 2024
7. JI Z, Zhu L, Wang X, Li H, et al
   Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study.
   Oncology. 2024 Nov 1. doi: 10.1159/000542369.
   

   >> Share

   
   October 2024
8. NAKAZAWA N, Sano A, Kumakura Y, Yamashita T, et al
   Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
   Oncology. 2024 Oct 24:1-17. doi: 10.1159/000541544.
   

   >> Share

   
   September 2024
9. HU Q, Kudo K, Yukaya T, Hasuda H, et al
   Clinical impact of skeletal muscle mass and nutritional status in patients with recurrent or advanced gastric cancer treated with nivolumab.
   Oncology. 2024 Sep 12:1-17. doi: 10.1159/000540840.
   

   >> Share

   
   
10. NAKAZAWA N, Sohda M, Hosoi N, Watanabe T, et al
    Identification of biomarkers for assessing treatment efficacy of chemotherapy plus nivolumab as the first line in patients with unresectable advanced or recurrent gastric cancer: a multicenter study.
    Oncology. 2024 Sep 12:1-17. doi: 10.1159/000540841.
    

    >> Share

    
    
11. NAKAMURA K, Suehiro Y, Hamabe K, Goto A, et al
    A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.
    Oncology. 2024 Sep 5:1-14. doi: 10.1159/000541173.
    

    >> Share

    
    July 2024
12. UCAR G, Sekmek S, Karahan I, Ergun Y, et al
    The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.
    Oncology. 2024 Jul 30. doi: 10.1159/000540517.
    

    >> Share

    
    February 2024
13. NEDOVIC VUKOVIC M, Jaksic M, Smolovic B, Lukic M, et al
    Trends in gastric cancer mortality in Montenegro, 1990 - 2018: joinpoint regression.
    Oncology. 2024 Feb 19. doi: 10.1159/000537739.
    

    >> Share

    
    
14. UNAL OU, Akay S, Gul G, Keser M, et al
    Impact of HER2-Low status in metastatic gastric cancer:A real-world retrospective cohort study.
    Oncology. 2024 Feb 14. doi: 10.1159/000537839.
    

    >> Share

    
    January 2024
15. JEON C, Kang SH, Kim SB, Paik NS, et al
    Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study.
    Oncology. 2024;102:465-475.
    

    >> Share

    
    December 2023
16. YAMAMOTO M, Omori T, Shinno N, Hara H, et al
    Prognostic value of a novel index combining the prognostic nutritional index and D-dimer levels for gastric cancer after gastrectomy.
    Oncology. 2023 Dec 30. doi: 10.1159/000533150.
    

    >> Share

    
    October 2023
17. ISHIKAWA A, Yasumatsu R, Fukui T, Kido A, et al
    Kinesin family member B18 is related to gastric mucin phenotype and contributes to gastric cancer progression by regulating epithelial-mesenchymal transition.
    Oncology. 2023 Oct 9. doi: 10.1159/000533791.
    

    >> Share

    
    September 2023
18. CORSO G, Trovato CM, Petitto S, Girardi A, et al
    Clinical implication of CDH1 mutations in genetic testing for diffuse gastric cancer patients.
    Oncology. 2023 Sep 19. doi: 10.1159/000533774.
    

    >> Share

    
    
19. MA J, Da M
    High-mobility group box 1 overexpression predicts a poor prognosis and promotes EMT in gastric cancer by activating TLR4/NF-kappaB signaling.
    Oncology. 2023 Sep 4. doi: 10.1159/000533927.
    

    >> Share

    
    July 2023
20. FUJIMOTO D, Taniguchi K, Takashima J, Kobayashi H, et al
    Postoperative early body weight loss is a risk factor for recurrence in patients with pStage III gastric cancer.
    Oncology. 2023 Jul 26. doi: 10.1159/000532089.
    

    >> Share

    
    June 2023
21. NAKAZAWA N, Sohda M, Katayama A, Ide M, et al
    Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with mTOR Signaling.
    Oncology. 2023 Jun 14. doi: 10.1159/000531475.
    

    >> Share

    
    
22. PECORA I, Ugolini C, Giannini R, Giordano M, et al
    Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy.
    Oncology. 2023 Jun 12. doi: 10.1159/000530853.
    

    >> Share

    
    
23. CHENG R, Peng Y, Sun X, Zhang S, et al
    Circulating tumor cells as diagnostic markers of early gastric cancer and gastric precancerous lesions.
    Oncology. 2023 Jun 1. doi: 10.1159/000531323.
    

    >> Share

    
    May 2023
24. ABEDINI F, Amjadi O, Hedayatizadeh-Omran A, Lira S, et al
    Serotonin Receptors and Acetylcholinesterase Gene Expression Alternations: The Potential Value on Tumor Microenvironment of Gastric Cancer.
    Oncology. 2023 May 3:1. doi: 10.1159/000530878.
    

    >> Share

    
    January 2023
25. HINGORANI M, Goody R, Bozas G, Zahid K, et al
    Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.
    Oncology. 2023;101:553-564.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share